Sandra Goble, MS
Sandra Goble, MS
Senior Manager, Biostatistics
Clovis Oncology Inc.
2525 28th Street
Boulder,
CO
USA
80301
Papers:
Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: interim results for ARIEL2 clinical trial